Viewing Study NCT01284166


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2025-12-29 @ 8:25 AM
Study NCT ID: NCT01284166
Status: WITHDRAWN
Last Update Posted: 2013-07-18
First Post: 2011-01-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Sponsor: Allergan
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Dorzo-Brimo-Timo/2010
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators